Beneficient Files S-1/A Update
Ticker: BENFW · Form: S-1/A · Filed: Oct 24, 2024 · CIK: 1775734
Sentiment: neutral
Topics: sec-filing, s-1/a, amendment
TL;DR
Beneficient dropped an S-1/A, check financials.
AI Summary
Beneficient filed an S-1/A on October 24, 2024, detailing its financial status. The company, incorporated in Nevada with its principal office in Dallas, TX, operates in Finance Services. Its fiscal year ends on March 31, and it previously operated as Beneficient Co Group, L.P. before a name change on May 3, 2019.
Why It Matters
This filing provides updated financial and operational information for Beneficient, which is crucial for investors and stakeholders to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — S-1/A filings often indicate a company is preparing for significant corporate actions like an IPO or major restructuring, which inherently carry risks.
Key Numbers
- 333-281694 — SEC File Number (Identifies the specific SEC registration for Beneficient)
- 241393385 — Film Number (Internal SEC processing number for the filing)
Key Players & Entities
- Beneficient (company) — Filer of the S-1/A
- 0001775734 (company) — Central Index Key for Beneficient
- 20241024 (date) — Filing date of the S-1/A
- 325 N. SAINT PAUL STREET SUITE 4850 DALLAS TX 75201 (address) — Business and mailing address of Beneficient
- Beneficient Co Group, L.P. (company) — Former company name
- 20190503 (date) — Date of former company name change
FAQ
What is the primary purpose of this S-1/A filing?
The S-1/A filing is an amendment to a previous registration statement, typically used to update information or respond to SEC comments before a securities offering or other significant corporate event.
When was Beneficient previously known by another name?
Beneficient was formerly known as Beneficient Co Group, L.P., with a name change occurring on May 3, 2019.
What is Beneficient's fiscal year end?
Beneficient's fiscal year ends on March 31.
Where is Beneficient's principal place of business located?
Beneficient's business and mailing address is 325 N. SAINT PAUL STREET, SUITE 4850, DALLAS, TX 75201.
What is the SEC file number associated with this filing?
The SEC file number is 333-281694.
Filing Stats: 4,709 words · 19 min read · ~16 pages · Grade level 15.8 · Accepted 2024-10-24 17:04:00
Key Financial Figures
- $0.001 — ares of Class A common stock, par value $0.001 ("Class A common stock") of Beneficient
- $4.0 million — "), in an aggregate principal amount of $4.0 million (the "Convertible Debentures"); 1,325
- $2.63 — A common stock at an exercise price of $2.63 we agreed to issue and sell to Yorkvill
- $250 million — eed to purchase from the Company, up to $250 million of the Company's shares of Class A comm
- $3.9 million — for an aggregate price of approximately $3.9 million. On June 20, 2024, the Company received
- $246.1 million — 27, 2023 under the SEPA. Approximately $246.1 million remains available under the SEPA. We ar
- $1 — tanding. Assuming a (i) Market Price of $1.23, the closing price of our Class A co
- $4.0 m — an aggregate principal amount of up to $4.0 million, which will be convertible into s
- $2.0 million — kville purchased and the Company issued $2.0 million in aggregate principal amount of Conver
- $3.6 million — roceeds to the Company of approximately $3.6 million. The Convertible Debentures are or will
- $1.3 million — payments of principal in the amount of $1.3 million (or such lesser amount as may then be o
- $3.018 — the Convertible Debentures) divided by $3.018 (the "Conversion Price"). The maximum a
- $2 — A common stock at an exercise price of $2.63, which shall be exercisable into Cla
- $1.23 — s price of the Class A common stock was $1.23 per share, and the last reported sales
- $0.0086 — sales price of our Public Warrants was $0.0086 per Public Warrant. We are an "emerging
Filing Documents
- forms-1a.htm (S-1/A) — 8628KB
- ex5-1.htm (EX-5.1) — 31KB
- ex23-1.htm (EX-23.1) — 3KB
- ex101616.htm (EX-10.16-16) — 19KB
- ex107.htm (EX-FILING FEES) — 46KB
- forms-1a_001.jpg (GRAPHIC) — 753KB
- image_001.jpg (GRAPHIC) — 5KB
- image_002.jpg (GRAPHIC) — 6KB
- image_003.jpg (GRAPHIC) — 6KB
- image_004.jpg (GRAPHIC) — 6KB
- image_005.jpg (GRAPHIC) — 202KB
- image_006.jpg (GRAPHIC) — 19KB
- image_007.jpg (GRAPHIC) — 207KB
- image_008.jpg (GRAPHIC) — 123KB
- image_009.jpg (GRAPHIC) — 162KB
- image_010.jpg (GRAPHIC) — 206KB
- image_011.jpg (GRAPHIC) — 232KB
- image_012.jpg (GRAPHIC) — 261KB
- image_013.jpg (GRAPHIC) — 243KB
- image_014.jpg (GRAPHIC) — 177KB
- image_015.jpg (GRAPHIC) — 92KB
- image_016.jpg (GRAPHIC) — 242KB
- image_017.jpg (GRAPHIC) — 155KB
- ex5-1_001.jpg (GRAPHIC) — 15KB
- ex5-1_002.jpg (GRAPHIC) — 6KB
- 0001493152-24-042391.txt ( ) — 36094KB
- benf-20240630.xsd (EX-101.SCH) — 148KB
- benf-20240630_cal.xml (EX-101.CAL) — 105KB
- benf-20240630_def.xml (EX-101.DEF) — 770KB
- benf-20240630_lab.xml (EX-101.LAB) — 931KB
- benf-20240630_pre.xml (EX-101.PRE) — 816KB
- forms-1a_htm.xml (XML) — 5690KB
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 79
BUSINESS
BUSINESS 143 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 178
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 188 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 210
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 237 DESCRIPTION OF SECURITIES 241 SELLING SECURITY HOLDER 280 PLAN OF DISTRIBUTION 288 LEGAL MATTERS 293 EXPERTS 294 WHERE YOU CAN FIND ADDITIONAL INFORMATION 295 INDEX TO FINANCIAL STATEMENTS F-1 i Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with SEC using a "shelf" registration process. The Selling Stockholders may, from time to time, sell the securities described in this prospectus. You should rely only on the information provided in this prospectus, as well as the information incorporated by reference into this prospectus and any applicable prospectus supplement. Neither we nor the Selling Stockholders have authorized anyone to provide you with different information. Neither we nor the Selling Stockholders have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Stockholders take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should not assume that the information in this prospectus or any applicable prospectus supplement is accurate as of any date other than the date of the applicable document. Since the date of this prospectus and the documents incorporated by reference into this prospectus, our business, financial condition, results of operations and prospects may have changed. Neither we nor the Selling Stockholders will make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to,